USE OF 4,4'-BIPYRIDINE BRIDGED TETRANUCLEAR PLATINUM COMPLEX IN PREPARATION OF ANTI-TELOMERASE NEGATIVE TUMOUR MEDICINE

摘要

Disclosed is a use of a 4,4'-bipyridine bridged tetranuclear platinum complex in the preparation of an anti-telomerase negative tumour medicine, wherein proliferation of telomerase negative tumour cells can be effectively inhibited.